Kimberlee C. Drapkin - Apr 1, 2022 Form 3 Insider Report for Acumen Pharmaceuticals, Inc. (ABOS)

Role
Director
Signature
/s/ Kimberlee C. Drapkin
Stock symbol
ABOS
Transactions as of
Apr 1, 2022
Transactions value $
$0
Form type
3
Date filed
4/4/2022, 05:09 PM
Previous filing
Feb 3, 2022
Next filing
Jun 17, 2022

No securities are beneficially owned.

Remarks:

No securities beneficially owned. Exhibit List - Exhibit 24 - Power of Attorney